Wave Life Sciences shares are trading higher after B. Riley Securities initiated coverage on the stock with a Buy rating and announced a price target of $11.
Portfolio Pulse from Benzinga Newsdesk
Wave Life Sciences shares rose after B. Riley Securities initiated coverage with a Buy rating and set a price target of $11.
September 19, 2024 | 7:49 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Wave Life Sciences shares increased following B. Riley Securities' initiation of coverage with a Buy rating and a price target of $11.
The initiation of coverage with a Buy rating and a specific price target by a reputable firm like B. Riley Securities is likely to boost investor confidence and drive short-term stock price increases.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100